Clinical Trials
2
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (100.0%)Focused Orticumab Research for Treating Inflammation in Coronary Arteries
Phase 2
Not yet recruiting
- Conditions
- Acute Coronary SyndromesCoronary Arterial Disease (CAD)InflammationHeart DiseaseMyocardial InfarctAtherosclerotic Coronary Vascular Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2025-04-15
- Last Posted Date
- 2025-04-17
- Lead Sponsor
- Abcentra
- Target Recruit Count
- 240
- Registration Number
- NCT06927739
A Proof-of-Activity Study With Orticumab in Subjects With Psoriasis and Cardiometabolic Risk Factors
Phase 2
Completed
- Conditions
- InflammationCardiometabolic SyndromePsoriasisCoronary Artery Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2021-03-02
- Last Posted Date
- 2024-02-02
- Lead Sponsor
- Abcentra
- Target Recruit Count
- 77
- Registration Number
- NCT04776629
- Locations
- 🇺🇸
CCT- Research at the center for Dermatology and Plastic Surgery, Scottsdale, Arizona, United States
🇺🇸Derm Institute & Skin Care Ctr., Inc., Santa Monica, California, United States
🇺🇸Orange County Research Center, Tustin, California, United States
News
No news found